Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data

PURPOSE: To develop a scoring system for hormone receptor-positive (HR+) breast cancer patients who are expected to achieve axillary pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). To confirm the correlation between axillary status and survival rate in HR+ breast cancer af...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jie, Zheng, Yiwen, Qian, Da, Guan, Dandan, Zheng, Qinghui, Xu, Yuhao, Ju, Siyi, Meng, Xuli, Tang, Hongchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797309/
https://www.ncbi.nlm.nih.gov/pubmed/36590310
http://dx.doi.org/10.1155/2022/6972703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797309/
https://www.ncbi.nlm.nih.gov/pubmed/36590310
http://dx.doi.org/10.1155/2022/6972703

Ejemplares similares